Deletion of the Murine Cytochrome P450 Locus by Fused BAC-Mediated Recombination Identifies a Role for in the Pulmonary Vascular Response to Hypoxia

English version České info

Epoxyeicosatrienoic acids (EETs) confer vasoactive and cardioprotective functions. Genetic analysis of the contributions of these short-lived mediators to pathophysiology has been confounded to date by the allelic expansion in rodents of the portion of the genome syntenic to human CYP2J2, a gene encoding one of the principle cytochrome P450 epoxygenases responsible for the formation of EETs in humans. Mice have eight potentially functional genes that could direct the synthesis of epoxygenases with properties similar to those of CYP2J2. As an initial step towards understanding the role of the murine Cyp2j locus, we have created mice bearing a 626-kb deletion spanning the entire region syntenic to CYP2J2, using a combination of homologous and site-directed recombination strategies. A mouse strain in which the locus deletion was complemented by transgenic delivery of BAC sequences encoding human CYP2J2 was also created. Systemic and pulmonary hemodynamic measurements did not differ in wild-type, null, and complemented mice at baseline. However, hypoxic pulmonary vasoconstriction (HPV) during left mainstem bronchus occlusion was impaired and associated with reduced systemic oxygenation in null mice, but not in null mice bearing the human transgene. Administration of an epoxygenase inhibitor to wild-type mice also impaired HPV. These findings demonstrate that Cyp2j gene products regulate the pulmonary vascular response to hypoxia.

Vyšlo v časopise: Deletion of the Murine Cytochrome P450 Locus by Fused BAC-Mediated Recombination Identifies a Role for in the Pulmonary Vascular Response to Hypoxia. PLoS Genet 9(11): e32767. doi:10.1371/journal.pgen.1003950
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003950

Souhrn

Zdroje

1. ZeldinDC, FoleyJ, MaJ, BoyleJE, PascualJM, et al. (1996) CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 50: 1111–1117.

2. GrossGJ, FalckJR, GrossER, IsbellM, MooreJ, et al. (2005) Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovasc Res 68: 18–25.

3. PokreiszP, FlemingI, KissL, Barbosa-SicardE, FisslthalerB, et al. (2006) Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 47: 762–770.

4. VoelkelNF, MorganrothM, FeddersenOC (1985) Potential role of arachidonic acid metabolites in hypoxic pulmonary vasoconstriction. Chest 88: 245S–248S.

5. CapecchiMR (2005) Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6: 507–512.

6. YangY, SeedB (2003) Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes. Nat Biotechnol 21: 447–451.

7. BarakatTS, RentmeesterE, SleutelsF, GrootegoedJA, GribnauJ (2011) Precise BAC targeting of genetically polymorphic mouse ES cells. Nucleic Acids Res 39: e121.

8. KlymiukN, MundhenkL, KraeheK, WuenschA, PlogS, et al. (2012) Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med (Berl) 90: 597–608.

9. LiZW, StarkG, GotzJ, RulickeT, GschwindM, et al. (1996) Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc Natl Acad Sci U S A 93: 6158–6162.

10. Van DeursenJ, FornerodM, Van ReesB, GrosveldG (1995) Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc Natl Acad Sci U S A 92: 7376–7380.

11. Ramirez-SolisR, LiuP, BradleyA (1995) Chromosome engineering in mice. Nature 378: 720–724.

12. NodeK, HuoY, RuanX, YangB, SpieckerM, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276–1279.

13. SpieckerM, LiaoJK (2005) Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 433: 413–420.

14. YangB, GrahamL, DikalovS, MasonRP, FalckJR, et al. (2001) Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60: 310–320.

15. GravesJP, EdinML, BradburyJA, GruzdevA, ChengJ, et al. (2013) Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily. Drug Metab Dispos 41: 763–773.

16. IchinoseF, UllrichR, SapirsteinA, JonesRC, BonventreJV, et al. (2002) Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. J Clin Invest 109: 1493–1500.

17. FischerLG, HollmannMW, HorstmanDJ, RichGF (2000) Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs. Anesth Analg 90: 625–631.

18. IchinoseF, ZapolWM, SapirsteinA, UllrichR, TagerAM, et al. (2001) Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res 88: 832–838.

19. ZhuD, BirksEK, DawsonCA, PatelM, FalckJR, et al. (2000) Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am J Physiol Heart Circ Physiol 279: H1526–1533.

20. ElderingE, SpekCA, AbersonHL, GrummelsA, DerksIA, et al. (2003) Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 31: e153.

21. MichaelisUR, FisslthalerB, MedhoraM, HarderD, FlemingI, et al. (2003) Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J 17: 770–772.

22. PozziA, Macias-PerezI, AbairT, WeiS, SuY, et al. (2005) Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. J Biol Chem 280: 27138–27146.

23. SeubertJ, YangB, BradburyJA, GravesJ, DegraffLM, et al. (2004) Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res 95: 506–514.

24. GebremedhinD, MaYH, FalckJR, RomanRJ, VanRollinsM, et al. (1992) Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 263: H519–525.

25. ImigJD, SimpkinsAN, RenicM, HarderDR Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med 13: e7.

26. RomanRJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131–185.

27. SchwartzmanML, MartasekP, RiosAR, LevereRD, SolangiK, et al. (1990) Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 37: 94–99.

28. AthirakulK, BradburyJA, GravesJP, DeGraffLM, MaJ, et al. (2008) Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J 22: 4096–4108.

29. LosapioJL, SpragueRS, LonigroAJ, StephensonAH (2005) 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. J Appl Physiol 99: 1391–1396.

30. KeseruB, Barbosa-SicardE, PoppR, FisslthalerB, DietrichA, et al. (2008) Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J 22: 4306–4315.

31. WangL, YinJ, NicklesHT, RankeH, TabuchiA, et al. (2012) Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest 122: 4218–4230.

32. BirksEK, BousamraM, PresbergK, MarshJA, EffrosRM, et al. (1997) Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue. Am J Physiol 272: L823–829.

33. RubinLJ, GrovesBM, ReevesJT, FrosolonoM, HandelF, et al. (1982) Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 66: 334–338.

34. ZeldinDC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059–36062.

35. YokoseT, DoyM, TaniguchiT, ShimadaT, KakikiM, et al. (1999) Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch 434: 401–411.

36. CaironiP, IchinoseF, LiuR, JonesRC, BlochKD, et al. (2005) 5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury. Am J Respir Crit Care Med 172: 334–343.

37. LangerakP, NygrenAO, SchoutenJP, JacobsH (2005) Rapid and quantitative detection of homologous and non-homologous recombination events using three oligonucleotide MLPA. Nucleic Acids Res 33: e188.

38. YuB, RaherMJ, VolpatoGP, BlochKD, IchinoseF, et al. (2008) Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117: 1982–1990.

39. BuysES, CauwelsA, RaherMJ, PasseriJJ, HobaiI, et al. (2009) sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. Am J Physiol Heart Circ Physiol 297: H654–663.

40. SteudelW, IchinoseF, HuangPL, HurfordWE, JonesRC, et al. (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81: 34–41.

41. FrancisRC, VaporidiK, BlochKD, IchinoseF, ZapolWM (2011) Protective and Detrimental Effects of Sodium Sulfide and Hydrogen Sulfide in Murine Ventilator-induced Lung Injury. Anesthesiology 115: 1012–1021.

42. ZeldinDC, PlitmanJD, KobayashiJ, MillerRF, SnapperJR, et al. (1995) The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. J Clin Invest 95: 2150–2160.

43. CapdevilaJH, FalckJR, DishmanE, KararaA (1990) Cytochrome P-450 arachidonate oxygenase. Methods Enzymol 187: 385–394.

44. FoxT, GotlingerKH, DunnMW, LeeOL, MilmanT, et al. (2013) Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis. Cornea 32: 1276–1282.